Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03208387 · ClinicalTrials.gov registry record
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
A clinical trial of Brain Tumor and Pediatric Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 42
- Enrollment target
- 4
- Study locations
NCT03208387: Active study of Brain Tumor and Pediatric Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03208387 is a study of Brain Tumor and Pediatric Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 42 participants, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03208387, a study of Brain Tumor and Pediatric Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 42 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this study is to learn about the cognitive and behavioral functioning of children being treated for cancer.
Primary Outcome
The study is a pilot study to collect information on feasibility broadly defined. The feasibility indicators are primarily descriptive variables, including a careful monitoring of accrual rate (how many eligible survivors consented per month).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Diffusion tensor imaging (DTI)
- DIAGNOSTIC_TEST Resting state functional connectivity MRI (rs-fcMRI)
- BEHAVIORAL Wechsler Intelligence Scale for Children - 5th edition (WISC-V)
- BEHAVIORAL California Verbal Learning Test (CVLT-C)
- BEHAVIORAL Beery Test of Visual Motor Integration 6th edition
Study Locations (4)
New York
- Columbia University - New York
- Memorial Sloan Kettering Cancer Center - New York
Texas
- University of Texas Southwestern Medical Center - Dallas
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2026-06 |
What the registry record for NCT03208387 still lists
NCT03208387 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Brain Tumor appearing as the primary indexed condition, and to 5 interventions - of which Diffusion tensor imaging (DTI) is the first listed.
NCT03208387 reports a single indexed study location in New York, Texas, Washington.
Frequently Asked Questions
What is clinical trial NCT03208387 about?
NCT03208387 is a clinical study titled "Understanding the Late Effects of Surviving a Pediatric Brain Tumor". The goal of this study is to learn about the cognitive and behavioral functioning of children being treated for cancer.
What is the current status of trial NCT03208387?
This trial is currently active not recruiting. The enrollment target is 42 participants. The study started on 2017-06-28. Estimated completion is 2026-06.
What conditions does trial NCT03208387 study?
This clinical trial studies the following conditions: Brain Tumor, Pediatric Cancer, Pediatric Brain Tumor.
What interventions are being tested in trial NCT03208387?
The interventions under investigation include: Diffusion tensor imaging (DTI) (DIAGNOSTIC_TEST), Resting state functional connectivity MRI (rs-fcMRI) (DIAGNOSTIC_TEST), Wechsler Intelligence Scale for Children - 5th edition (WISC-V) (BEHAVIORAL), California Verbal Learning Test (CVLT-C) (BEHAVIORAL), Beery Test of Visual Motor Integration 6th edition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03208387?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03208387 being conducted?
This trial has 4 study locations across New York, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03208387's enrollment target sits among peer trials
42 36th of 69 higher than 34 of 69 other Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
RECRUITING
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI